4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000185
Chief Executive Officer sold 4,536 shares at an average $78.49 ($356,012)
- Chief Executive Officer acquired 4,536 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monia Brett P Chief Executive Officer | 2026-05-13 | Option exercise 10b5-1 | +1,316 | $32.60 | $42,902 | 243,978 | D: show line 1 in the form |
| Monia Brett P Chief Executive Officer | 2026-05-13 | Sale 10b5-1 | −1,316 | $78.01 | $102,665 | 242,662 | D: show line 2 in the form |
| Monia Brett P Chief Executive Officer | 2026-05-14 | Option exercise 10b5-1 | +3,220 | $32.60 | $104,972 | 245,882 | D: show line 3 in the form |
| Monia Brett P Chief Executive Officer | 2026-05-14 | Sale 10b5-1 | −3,220 | $78.68 | $253,347 | 242,662 | D: show line 4 in the form |
| Open-market sales · 4,536 sh · avg $78.49 · $356,012 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monia Brett P Chief Executive Officer | 2026-05-13 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,316 | 38,857 | D: show line 5 in the form | ||
| Monia Brett P Chief Executive Officer | 2026-05-14 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −3,220 | 35,637 | D: show line 6 in the form |
Loading xslF345X06/edgardoc.xml…